Spruce Biosciences, Inc.
USD49.05
-0.25 (-0.51%)
CEO
Javier Szwarcberg
IPO Date
2020-10-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$48.09
Prev. Close
$49.30
Day Low
$48.00
Day High
$50.50
52W Low
$7.00
52W High
$838.13
Market Cap
$0.07B
Volume
0.06M
| 1,700 |
| $52.70 |
| 26 May 2026 | GREY MICHAEL G | director, officer: Executive Chairman | A-Award | Acquired | 1,700 | $52.70 |
| 26 May 2026 | Barretto-Ko Percival | director | A-Award | Acquired | 1,700 | $52.70 |
| 26 May 2026 | Walbert Keli | director | A-Award | Acquired | 1,700 | $52.70 |
| 9 Mar 2026 | Hooks Corwin Dale | Chief Commercial Officer | A-Award | Acquired | 11,000 | $0.00 |
| 9 Mar 2026 | Hooks Corwin Dale | — | Disposed | 0 | $0.00 |
| 21 Jan 2026 | Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | D-Return | Disposed | 266 | $791.25 |
| 21 Jan 2026 | Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | A-Award | Acquired | 266 | $104.13 |
| 21 Jan 2026 | Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | D-Return | Disposed | 400 | $169.50 |